(Circulation. 1997;95:1568-1576.)
© 1997 American Heart Association, Inc.
Articles |
From the Department of Physiology, Faculty of Medicine, Université de Montréal and Institut de Cardiologie de Montréal (Québec), Canada.
Correspondence to Michel Lavallée, Institut de Cardiologie de Montréal, 5000, Bélanger St E, Montréal, Québec, Canada H1T 1C8.
Background We considered that ß2-adrenergic stimulation may dilate resistance coronary vessels by opening ATP-sensitive potassium (KATP) channels, thereby triggering NO formation.
Methods and Results In conscious instrumented dogs after
ß1-adrenergic blockade, intracoronary (IC) injections of
acetylcholine (ACh), nitroglycerin (NTG), and pirbuterol (PIR), a
selective ß2-adrenergic agonist, were performed before
and after blockade of NO formation with IC
N
-nitro-L-arginine methyl ester
(L-NAME, 50
µg·kg-1·min-1x12
minutes) or blockade of KATP channels with IC glibenclamide
(25
µg·kg-1·min-1x12
minutes followed by 2
µg·kg-1·min-1).
PIR (50.0 ng/kg) increased coronary blood flow (CBF) by 32±6 from
43±7 mL/min and by only 11±2 (P<.01) from 40±7 mL/min
after L-NAME. Increases in CBF to ACh were also reduced by L-NAME, but
NTG responses were not. Before glibenclamide, PIR increased CBF by
33±5 from 45±7 mL/min and by only 14±3 (P<.01) from
36±5 mL/min thereafter. CBF responses to ACh and NTG were maintained
after glibenclamide. Lemakalim, a selective opener of KATP
channels, caused dose-dependent increases in CBF that were partially
inhibited by L-NAME. In experiments in which CBF was controlled, the
fall in distal coronary pressure caused by PIR was less after L-NAME or
glibenclamide than before.
Conclusions ß2-Adrenergic dilation of resistance coronary vessels involves both the opening of KATP channels and NO formation. L-NAME antagonized lemakalim responses consistent with a link between the opening of KATP channels and NO formation in canine resistance coronary vessels.
Key Words: endothelium endothelium-derived factors microcirculation receptors, adrenergic, beta
This article has been cited by other articles:
![]() |
Y. Shi, Z. Wu, N. Cui, W. Shi, Y. Yang, X. Zhang, A. Rojas, B. T. Ha, and C. Jiang PKA phosphorylation of SUR2B subunit underscores vascular KATP channel activation by beta-adrenergic receptors Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1205 - R1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fernandez, L. Monge, A. L. Garcia-Villalon, and G. Dieguez Coronary reactive hyperaemia and arterial pressure in anaesthetized goats Exp Physiol, September 1, 2006; 91(5): 915 - 923. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lei, K. Matsuo, V. Labinskyy, N. Sharma, M. P. Chandler, A. Ahn, T. H. Hintze, W. C. Stanley, and F. A. Recchia Exogenous nitric oxide reduces glucose transporters translocation and lactate production in ischemic myocardium in vivo PNAS, May 10, 2005; 102(19): 6966 - 6971. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Hein, C. Zhang, W. Wang, and L. Kuo Heterogeneous {beta}2-Adrenoceptor Expression and Dilation in Coronary Arterioles Across the Left Ventricular Wall Circulation, October 26, 2004; 110(17): 2708 - 2712. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okajima, R. Parent, E. Thorin, and M. Lavallee Pathophysiological plasma ET-1 levels antagonize {beta}-adrenergic dilation of coronary resistance vessels in conscious dogs Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1476 - H1483. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gellman, J. M. Hare, C. J. Lowenstein, G. Gerstenblith, V. Coombs, P. Langenberg, J. A. Brinker, and J. R. Resar L-Arginine Ameliorates the Abnormal Sympathetic Response of the Dysfunctional Human Coronary Microvasculature Angiology, January 1, 2004; 55(1): 1 - 8. [Abstract] [PDF] |
||||
![]() |
X.-P. Zhang, H. Tada, Z. Wang, and T. H. Hintze cAMP Signal Transduction, A Potential Compensatory Pathway for Coronary Endothelial NO Production After Heart Failure Arterioscler. Thromb. Vasc. Biol., August 1, 2002; 22(8): 1273 - 1278. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sun, A. Huang, S. Mital, M. R. Kichuk, C. C. Marboe, L. J. Addonizio, R. E. Michler, A. Koller, T. H. Hintze, and G. Kaley Norepinephrine Elicits {beta}2-Receptor-Mediated Dilation of Isolated Human Coronary Arterioles Circulation, July 30, 2002; 106(5): 550 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang and T. H. Hintze cAMP Signal Transduction Cascade, a Novel Pathway for the Regulation of Endothelial Nitric Oxide Production in Coronary Blood Vessels Arterioscler. Thromb. Vasc. Biol., May 1, 2001; 21(5): 797 - 803. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. W. Broeders, P. A. Doevendans, B. C. A. M. Bekkers, R. Bronsaer, E. van Gorsel, J. W. M. Heemskerk, M. G. A. o. Egbrink, E. van Breda, R. S. Reneman, and R. van der Zee Nebivolol: A Third-Generation {beta}-Blocker That Augments Vascular Nitric Oxide Release : Endothelial {beta}2-Adrenergic Receptor-Mediated Nitric Oxide Production Circulation, August 8, 2000; 102(6): 677 - 684. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pagliaro, N. Paolocci, T. Isoda, W. F Saavedra, G. Sunagawa, and D. A Kass Reversal of glibenclamide-induced coronary vasoconstriction by enhanced perfusion pulsatility: possible role for nitric oxide Cardiovasc Res, March 1, 2000; 45(4): 1001 - 1009. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fujii, U. Onaka, K. Goto, I. Abe, and M. Fujishima Impaired Isoproterenol-Induced Hyperpolarization in Isolated Mesenteric Arteries of Aged Rats Hypertension, August 1, 1999; 34(2): 222 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kakoki, Y. Hirata, H. Hayakawa, H. Nishimatsu, Y. Suzuki, D. Nagata, E. Suzuki, K. Kikuchi, T. Nagano, and M. Omata Effects of Vasodilatory ß-Adrenoceptor Antagonists on Endothelium-Derived Nitric Oxide Release in Rat Kidney Hypertension, January 1, 1999; 33(1): 467 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ming, R. Parent, E. Thorin, and M. Lavallee Endothelin-Dependent Tone Limits Acetylcholine-Induced Dilation of Resistance Coronary Vessels After Blockade of NO Formation in Conscious Dogs Hypertension, November 1, 1998; 32(5): 844 - 848. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takamura, R. Parent, and M. Lavallee Enhanced contribution of NO to exercise-induced coronary responses after alpha -adrenergic receptor blockade Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H508 - H515. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |